Login / Signup

Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y 12 Inhibitors and Their Association with Platelet Function.

Karolina GumiężnaAdrian BednarekGrażyna SygitowiczAgata Maciejak-JastrzębskaPiotr BaruśJaromir HuniaDominika Klimczak-TomaniakJanusz KochmanMarcin GrabowskiMariusz Tomaniak
Published in: Journal of clinical medicine (2023)
The identified platelet miRs hold potential as biomarkers for antiplatelet therapy. (ClinicalTrials.gov number, NCT06177587).
Keyphrases
  • antiplatelet therapy
  • acute coronary syndrome
  • percutaneous coronary intervention
  • coronary artery disease
  • human health
  • risk assessment